Key to Learning and Forgetting Identified in Sleeping Brain
Distinct patterns of electrical activity in the sleeping brain may influence whether we remember or forget what we learned the previous day.
University of California San Francisco
Give to UCSF
Stem Cell Studies Offer Hope for Childhood Neurological Condition
International team of researchers report progress in using stem cells to develop new therapies for Pelizaeus-Merzbacher disease, a rare genetic condition affecting boys that can be fatal before 10 years of age.
Monthly Phone Check-In May Mean Less Depression for Families of Patients with Dementia
A monthly, 40-minute phone call from a non-clinical professional may suppress or reverse the trajectory of depression so frequently experienced by family members caring for patients with dementia at home.
Genetically Tailored Instruction Improves Songbird Learning
UCSF study conducted in songbirds shows that what at first appear to be genetic constraints on birds’ song learning abilities could be largely eliminated by tailoring instruction to better match the birds’ inborn predispositions.
After 10-Year Search, Scientists Find Second ‘Short Sleep’ Gene
UCSF scientists who identified the only human gene known to promote “natural short sleep” have discovered a second.
Elderly Have Poor Prognosis After Recovery in Long-Term Acute Care Hospitals
While long-term acute care hospitals are designed to help patients recover and regain independence, fewer than 1-in-5 older adults who were transferred to such facilities were alive five years later.
Simple Blood Test Unmasks Concussions Absent on CT Scans
Blood test that is currently under development may flag concussion in CT-negative patients, enabling them to be evaluated for long-term complications.
Scorpion Toxin That Targets ‘Wasabi Receptor’ May Help Solve Mystery of Chronic Pain
Researchers discovered a scorpion toxin that targets the “wasabi receptor,” which they think it can be used as a tool for studying chronic pain and inflammation, and may eventually lead to the development of new kinds of non-opioid pain relievers.
